9n9l: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "9n9l" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 5: | Line 5: | ||
Authors: Spurlino, J.C., Milligan, C. | Authors: Spurlino, J.C., Milligan, C. | ||
Description: An RORgt Inverse agonist for treatment of Psoriasis | Description: An RORgt Inverse agonist for treatment of Psoriasis | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Milligan, C]] | [[Category: Milligan, C]] | ||
[[Category: Spurlino, J.C]] | [[Category: Spurlino, J.C]] | ||
Revision as of 17:31, 26 February 2025
Unreleased structure
The entry 9n9l is ON HOLD
Authors: Spurlino, J.C., Milligan, C.
Description: An RORgt Inverse agonist for treatment of Psoriasis
